Citations

Showing 10 of 108104 citations.

The Effects of Website and Social Media Presence of Integrated Plastic Surgery Residency Programs on Prospective Applicants
Deckey, David G. , Brinkman, Joseph C. , Casey, William J., Teven, Chad M. , Tummala, Sailesh V , Pflibsen, Lacey R. , Tummala, Sailesh V.

Mayo Clinic

Annals of Plastic Surgery | January 24, 2022 | Volume: 88 | Issue: 6 | Pages: 599-605

10.1097/sap.0000000000003064 | PMID 35612533 Get It

Purpose Integrated plastic surgery residency programs have increased their social media presence to educate and recruit prospective residents. This study aims to understand the impact of integrated plastic surgery residency program social media on the 2020 to 2021 applicants' evaluation of prospective programs, particularly during the coronavirus disease 2019 pandemic. Materials and Methods An optional 20-item online survey was sent to integrated plastic surgery residency applicants applying to the authors' program. Results Surveys were sent to 300 integrated plastic surgery residency applicants with an average of 168 responses (56% response rate). Social media resources included official residency program website (87.1%), Instagram (70.2%), and Doximity (46.8%). The most frequently used resource by applicants was the official residency program website (43.9%); Instagram was the second most frequently used (40.2%) followed by Doximity (8.3%). Most respondents agreed that social media was an effective means to inform applicants (66.1%), and it positively impacted their perception of the program (64.8%). The cited benefits were helping the program exhibit its culture and comradery among residents, faculty, and staff (78.4%). Among applicants, 73.6% noted that it had a significant impact on their perceptions of programs. Most respondents truncated their planned plastic surgery subinternships, completing 1 instead of 3 planned subinternships because of coronavirus disease 2019 limitations. Conclusions During the 2020 to 2021 plastic surgery application cycle, applicants used social media accounts of plastic surgery residency programs to inform and educate themselves about prospective programs. This study suggests that investing resources into a social media residency accounts is a meaningful pursuit for integrated plastic surgery programs and is an important aspect in today's recruitment.
Intraoperative Fluid Management a Modifiable Risk Factor for Surgical Quality – Improving Standardized Practice
Aziz, Mohamed A. Abd El, Grass, Fabian, Calini, Giacomo, Lovely, Jenna K., Jacob, Adam K., Behm, Kevin T., D’Angelo, Anne-Lise D., Shawki, Sherief F., Mathis, Kellie L., Larson, David W., Calini, Giacomo , Calini, G , Aziz, Mohamed A. Abd El, Grass, Fabian, Lovely, Jenna K., Jacob, Adam K., Behm, Kevin T., D’Angelo, Anne-Lise D., Shawki, Sherief F., Mathis, Kellie L., Larson, David W.

Mayo Clinic

Annals of Surgery | January 24, 2022 | Volume: 275 | Issue: 5 | Pages: 891-896

10.1097/sla.0000000000005384 | PMID 35129473 Get It

Objective: We aimed to determine a safe zone of intraoperative fluid management associated with the lowest postoperative complication rates without increased acute kidney injury (AKi) risk for elective colorectal surgery patients. Background: To date, standard practice within institutions, let alone national expectations related to fluid administration, are limited. This fact has perpetuated a quality gap. Methods: Elective colorectal surgeries between 2018 and 2020 were included. Unadjusted odds ratios (ORs) for postoperative ileus, prolonged LOS, and AKi were plotted against the rate of intraoperative RL infusion (mL/ kg/h) and total intraoperative volume. Binary logistic regression analysis, including fluid volumes as a confounder, was used to identify risk factors for postoperative complications. Results: A total of 2900 patients were identified. Of them, 503 (17.3%) patients had ileus, 772 (26.6%) patients had prolonged LOS, and 240 (8.3%) patients had AKI. The intraoperative fluid resuscitation rate (mg/kg/h) was less impactful on postoperative ileus, LOS, and AKI than the total amount of intraoperative fluid. A total fluid administration range between 300 mL and 2.7 L was associated with the lowest complication rate. Total intraoperative RL ≥2.7 L was independently associated with a higher risk of ileus (adjusted OR 1.465; 95% confidence interval 1.154–1.858) and prolonged LOS (adjusted OR 1.300; 95% confidence interval 1.047–1.613), but not AKI. Intraoperative RL ≤300 mL was not associated with an increased risk of AKI. Conclusion: Total intraoperative RL ≥2.7 L was independently associated with postoperative ileus and prolonged LOS in elective colorectal surgery patients. A new potential standard for intraoperative fluids will require anesthesia case planning (complexity and duration) to ensure total fluid volume meets this new opportunity to improve care.
Autologous CD34+ Stem Cell Therapy Increases Coronary Flow Reserve and Reduces Angina in Patients With Coronary Microvascular Dysfunction
Henry, Timothy D. , Merz, C. Noel Bairey , Wei, Janet , Corban, Michel T., Quesada, Odayme, Joung, Sandy , Kotynski, Christine L., Wang, Jian, Lewis, Michelle, Schumacher, Ann M., Bartel, Ronnda L., Takagi, Hiroshi, Shah, Vishal, Lee, Anna, Losordo, Douglas W., Bairey Merz, C Noel , Sietsema, William K , Lerman, Amir , Wei, Janet , Henry, Timothy D , Corban, Michel T., Quesada, Odayme, Joung, Sandy , Kotynski, Christine L., Wang, Jian, Lewis, Michelle, Schumacher, Ann M., Bartel, Ronnda L., Takagi, Hiroshi, Shah, Vishal, Lee, Anna, Losordo, Douglas W.

Mayo Clinic

Circulation: Cardiovascular Interventions | January 24, 2022 | Volume: 15 | Issue: 2 | Pages: No page available

10.1161/circinterventions.121.010802 | PMID 35067072 Get It

Background: Coronary microvascular dysfunction results in angina and adverse outcomes in patients with evidence of ischemia and nonobstructive coronary artery disease; however, no specific therapy exists. CD34+ cell therapy increases microvasculature in preclinical models and improves symptoms, exercise tolerance, and mortality in refractory angina patients with obstructive coronary artery disease. The objective of this research was to evaluate the safety, tolerability, and efficacy of intracoronary CD34+ cell therapy in patients with coronary microvascular dysfunction. Methods: We conducted a 2-center, 20-participant trial of autologous CD34+ cell therapy (protocol CLBS16-P01; NCT03508609) in patients with ischemia and nonobstructive coronary artery disease with persistent angina and coronary flow reserve ≤2.5. Efficacy measures included coronary flow reserve, angina frequency, Canadian Cardiovascular Society angina class, Seattle Angina Questionnaire, SF-36, and modified Bruce exercise treadmill test obtained at baseline and 6 months after treatment. Autologous CD34+ cells (CLBS16) were mobilized by administration of granulocyte-colony stimulating factor 5µg/kg/day for 5 days and collected by leukapheresis. Participants received a single intracoronary left anterior descending infusion of isolated CD34+ cells in medium that enhances cell function. Results: Coronary flow reserve improved from 2.08±0.32 at baseline to 2.68±0.79 at 6 months after treatment ( P <0.005). Angina frequency decreased ( P <0.004), Canadian Cardiovascular Society class improved ( P <0.001), and quality of life improved as assessed by the Seattle Angina Questionnaire ( P ≤0.03, all scales) and SF-36 ( P ≤0.04, all scales). There were no cell-related serious adverse events. Conclusions: In this pilot clinical trial of microvascular angina, patients with ischemia and nonobstructive coronary artery disease receiving intracoronary infusion of CD34+ cell therapy had higher coronary flow reserve, less severe angina, and better quality of life at 6 months. The current study supports a potential therapeutic role for CD34+ cells in patients with microvascular angina. Registration: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT03508609.
Composite Classic Hodgkin Lymphoma and Follicular Lymphoma
Huang, Yuhua, Hu, Shimin, Larson, Daniel P., Shi, Min, He, Rong, Dave, Bhavana J., Greiner, Timothy C., Fu, Kai, McPhail, Ellen D., Ketterling, Rhett P., Medeiros, L. Jeffrey, Yuan, Ji, Ji, Yuan , Hu, Shimin , Hu, Shimin , Yuan, Ji , Huang, Yuhua, Hu, Shimin, Larson, Daniel P., Shi, Min, He, Rong, Dave, Bhavana J., Greiner, Timothy C., Fu, Kai, McPhail, Ellen D., Ketterling, Rhett P., Medeiros, L. Jeffrey, Yuan, Ji

Mayo Clinic

American Journal of Surgical Pathology | January 24, 2022 | Volume: 46 | Issue: 6 | Pages: 793-800

10.1097/pas.0000000000001828 | PMID 35067515 Get It

Composite classic Hodgkin lymphoma and follicular lymphoma (CHLFL) is a rare and poorly characterized entity. Herein, we report the clinicopathologic features of 22 cases of CHLFL from 3 institutions and we assess 27 additional cases reported in the literature. In our cohort (n=22), patients with CHLFL had a median age of 61 years and an equal male to female incidence. Most cases (95%) arose de novo with the remaining patients having a history of non-Hodgkin lymphoma. CHLFL always involved lymph nodes (100%) and most cases (95%) revealed 2 distinct areas separately diagnostic for CHL and FL. The CHL component represented a variable proportion of the overall neoplasm (5% to 90%) and was either mixed cellularity (82%) or nodular sclerosis (18%) type. The Hodgkin/Reed-Sternberg cells expressed CD30 (100%), PAX5 (100%), CD15 (62%), BCL6 (47%), BCL2 (29%), and EBER (25%), in a polymorphous inflammatory background typical of CHL. The FL component was low-grade in 55%, grade 3A in 36%, and grade 3B in 9% of cases. All 3 cases investigated by cytogenetic methods for a clonal relationship between the CHL and FL components were clonally related. These clinicopathologic features of our cohort are similar to those of cases reported in the literature. The 5-year overall survival in combined patients with CHLFL (n=49) was 48%, comparable to CHL but worse than FL in the elderly. In summary, CHLFL is a rare entity that most often occurs in older adults, involves lymph nodes, and most commonly presents de novo. In the small number of cases assessed, the CHL and FL components are usually clonally related suggesting that the CHL and FL components may share a common progenitor B-cell, likely a mutated germinal center B-cell.
Healthy and unhealthy aging on kidney structure and function: human studies
Denic, Aleksandar, Rule, Andrew D., Glassock, Richard J., Đenić, Aleksandar , Denic, Aleksandar , Rule, Andrew D., Glassock, Richard J.

Mayo Clinic

Current Opinion in Nephrology & Hypertension | January 24, 2022 | Volume: 31 | Issue: 3 | Pages: 228-234

10.1097/mnh.0000000000000780 | PMID 35067600 Get It

Purpose of review This review is intended to provide an up-to-date analysis of the structural and functional alterations of the kidneys that accompany healthy and unhealthy aging in humans. Macro- and micro- structural changes and glomerular filtration rate (whole kidney and single nephron) accompanying aging will be stressed. Recent findings Comparative findings concerning distribution of anatomic changes of the kidney healthy and unhealthy aging are reviewed. Challenges concerning definition of chronic kidney disease (CKD) in otherwise healthy aging patients are discussed. The complex interactions of CKD and aging are discussed. The role of podocyte dysbiosis in kidney aging is reviewed. Summary Kidney aging is a complex phenomenon often difficult to distinguish from CKD. Nonetheless, phenotypes of healthy and unhealthy aging are evident. Much more information concerning the molecular characteristics of normal kidney aging and its relevance to chronic kidney disease is needed.
A Multicenter Comparison of Open Versus Arthroscopic Fixation for Pediatric Tibial Spine Fractures
Shimberg, Jilan L. , Leska, Tomasina M. , Cruz, Aristides I., Ellis, Henry B., Tj, Ganley, Johnson, Ben, Milbrandt, Todd A., Yen, Yi-Meng, Mistovich, R. Justin , Cruz, Aristides I. , Patel, Neeraj M. , Ellis, Henry B. , Ganley, Theodore J. , Johnson, Ben, Milbrandt, Todd A. , Yen, Yi‐Meng

Mayo Clinic

Journal of Pediatric Orthopaedics | January 23, 2022 | Volume: 42 | Issue: 4 | Pages: 195-200

10.1097/bpo.0000000000002049 | PMID 35067605 Get It

Background: When operative treatment is indicated, tibial spine fractures can be successfully managed with open or arthroscopic reduction and internal fixation (ARIF). The purpose of the study is to evaluate short-term treatment outcomes of tibial spine fractures in patients treated with both open and arthroscopic fracture reduction. Methods: We performed an Institutional Review Board (IRB)-approved retrospective cohort study of pediatric tibial spine fractures presenting between January 1, 2000 and January 31, 2019 at 10 institutions. Patients were categorized into 2 cohorts based on treatment: ARIF and open reduction and internal fixation (ORIF). Short-term surgical outcomes, the incidence of concomitant injuries, and surgeon demographics were compared between groups. Results: There were 477 patients with tibial spine fractures who met inclusion criteria, 420 of whom (88.1%) were treated with ARIF, while 57 (11.9%) were treated with ORIF. Average follow-up was 1.12 years. Patients treated with ARIF were more likely to have an identified concomitant injury (41.4%) compared with those treated with ORIF (24.6%, P=0.021). Most concomitant injuries (74.5%) were treated with intervention. The most common treatment complications included arthrofibrosis (6.9% in ARIF patients, 7.0% in ORIF patients, P=1.00) and subsequent anterior cruciate ligament injury (2.1% in ARIF patients and 3.5% in ORIF, P=0.86). The rate of short-term complications, return to the operating room, and failure to return to full range of motion were similar between treatment groups. Twenty surgeons with sports subspecialty training completed 85.0% of ARIF cases; the remaining 15.0% were performed by 12 surgeons without additional sports training. The majority (56.1%) of ORIF cases were completed by 14 surgeons without sports subspecialty training. Conclusion: This study demonstrated no difference in outcomes or nonunion following ARIF or ORIF, with a significantly higher rate of concomitant injuries identified in patients treated with ARIF. The majority of identified concomitant injuries were treated with surgical intervention. Extensive surgical evaluation or pretreatment magnetic resonance imaging should be considered in the workup of tibial spine fractures to increase concomitant injury identification. Level of Evidence: Level III.
Biocompatible Core–Shell-Structured Si-Based NiO Nanoflowers and Their Anticancer Activity
Gwon, Kihak , Park, Jongdeok , Lee, Seonhwa , Gwon, Kihak , Yu, Jong‐Sung , Lee, Do Nam

Mayo Clinic

Pharmaceutics | January 23, 2022 | Volume: 14 | Issue: 2 | Pages: 268

10.3390/pharmaceutics14020268 | PMID 35214001 Get It

Compared to most of nano-sized particles, core–shell-structured nanoflowers have received great attention as bioactive materials because of their high surface area with the flower-like structures. In this study, core–shell-structured Si-based NiO nanoflowers, Si@NiO, were prepared by a modified chemical bath deposition method followed by thermal reduction. The crystal morphology and basic structure of the composites were characterized by powder X-ray diffraction (PXRD), Fourier-transform infrared spectroscopy (FT-IR), scanning electron microscopy (SEM), transmission electron microscopy (TEM), specific surface area (BET) and porosity analysis (BJT), and inductively coupled plasma optical emission spectrometry (ICP-OES). The electrochemical properties of the Si@NiO nanoflowers were examined through the redox reaction of ascorbic acid with the metal ions present on the surface of the core–shell nanoflowers. This reaction favored the formation of reactive oxygen species. The Si@NiO nanoflowers showed excellent anticancer activity and low cytotoxicity toward the human breast cancer cell line (MCF-7) and mouse embryonic fibroblasts (MEFs), respectively, demonstrating that the anticancer activities of the Si@NiO nanoflowers were primarily derived from the oxidative capacity of the metal ions on the surface, rather than from the released metal ions. Thus, this proves that Si-based NiO nanoflowers can act as a promising candidate for therapeutic applications.
Evaluating the Evidence in Clinical Studies of Vitamin D in COVID-19
Thacher, Tom D. , Thacher, Thomas D

Mayo Clinic

Nutrients | January 23, 2022 | Volume: 14 | Issue: 3 | Pages: 464

10.3390/nu14030464 | PMID 35276822 Get It

Laboratory evidence provides a biological rationale for the benefits of vitamin D in COVID-19, and vitamin D supplementation is associated with reduced risk of respiratory infections. Most of the clinical studies of vitamin D in COVID-19 have been observational, and the most serious problem with observational study design is that of confounding. Observational studies typically assess the relationship of 25(OH)D values with COVID-19 outcomes. Many conditions associated with low vitamin D status are also associated with worse COVID-19 outcomes. Randomized controlled trials (RCTs) overcome the problem of confounding, typically comparing outcomes between groups receiving vitamin D supplementation or placebo. However, any benefit of vitamin D in COVID-19 may be related to the dose, duration, daily vs. bolus administration, interaction with other treatments, and timing of administration prior to or during the illness. Serum 25(OH)D values >50 nmol/L have been associated with reduced infection rates, severity of COVID-19, and mortality in observational studies. Few RCTs of vitamin D supplementation have been completed, and they have shown no benefit of vitamin D in hospitalized patients. Vitamin D may benefit those with mild or asymptomatic COVID-19, and those with greater 25(OH)D values may have lower risk of acquiring infection. Because those at greatest risk of COVID-19 are also at greatest risk of vitamin D deficiency, it is reasonable to recommend vitamin D supplementation 15–20 mcg (600–800 IU) daily for the general population during the COVID-19 pandemic. Vitamin D doses greater than 100 mcg (4000 IU) daily should not be used without monitoring serum 25(OH)D and calcium.
The Combined Effects of Television Viewing and Physical Activity on Cardiometabolic Risk Factors: The Kardiovize Study
Neto, Geraldo de Albuquerque Maranhão , Pavlovska, Iuliia , Polcrová, Anna Bartošková , Infante-García, María M., Medina‐Inojosa, José R. , Nieto‐Martínez, Ramfis , Lopez‐Jimenez, Francisco, González‐Rivas, Juan P. , Maranhao Neto, Geraldo A , Polcrova, Anna , Medina-Inojosa, José R , Nieto-Martinez, Ramfis , González-Rivas, Juan P , Mechanick, Jeffrey I. , López-Jiménez, Francisco

Mayo Clinic

Journal of Clinical Medicine | January 23, 2022 | Volume: 11 | Issue: 3 | Pages: 545

10.3390/jcm11030545 | PMID 35159997 Get It

The aim of the present study was to evaluate the association between television viewing/physical activity (TVV/PA) interactions and cardiometabolic risk in an adult European population. A total of 2155 subjects (25–64 years) (45.2% males), a random population-based sample were evaluated in Brno, Czechia. TVV was classified as low (<2 h/day), moderate (2–4), and high (≥4). PA was classified as insufficient, moderate, and high. To assess the independent association of TVV/PA categories with cardiometabolic variables, multiple linear regression was used. After adjustments, significant associations were: High TVV/insufficient PA with body mass index (BMI) (β = 2.61, SE = 0.63), waist circumference (WC) (β = 7.52, SE = 1.58), body fat percent (%BF) (β = 6.24, SE = 1.02), glucose (β = 0.25, SE = 0.12), triglycerides (β = 0.18, SE = 0.05), and high density lipoprotein (HDL-c) (β = −0.10, SE = 0.04); high TVV/moderate PA with BMI (β = 1.98, SE = 0.45), WC (β = 5.43, SE = 1.12), %BF (β = 5.15, SE = 0.72), triglycerides (β = 0.08, SE = 0.04), total cholesterol (β = 0.21, SE = 0.10), low density protein (LDL-c) (β = 0.19, SE = 0.08), and HDL-c (β = −0.07, SE = 0.03); and moderate TVV/insufficient PA with WC (β = 2.68, SE = 1.25), %BF (β = 3.80, SE = 0.81), LDL-c (β = 0.18, SE = 0.09), and HDL-c (β = −0.07, SE = 0.03). Independent of PA levels, a higher TVV was associated with higher amounts of adipose tissue. Higher blood glucose and triglycerides were present in subjects with high TVV and insufficient PA, but not in those with high PA alone. These results affirm the independent cardiometabolic risk of sedentary routines even in subjects with high-levels of PA.
Impact of mitral intervention on outcomes of patients with mitral valve dysfunction and annulus calcification
Kato, Nahoko , Pellikka, Patricia A. , Lee, Alexander T., Jain, Vaibhav , Eleid, Mackram F. , Reeder, Guy S., Bagameri, Gabor, Rihal, Charanjit S. , Eleid, Mackram F , Alkhouli, Mohamad A, Guerrero, Mayra E , Pellikka, Patricia A , Scott, Christopher G. , Alkhouli, Mohamad , Michelena, Héctor I. , Pislaru, Sorin V. , Crestanello, Juan A. , Rihal, Charanjit S. , Guerrero, Mayra

Mayo Clinic

Catheterization and Cardiovascular Interventions | January 23, 2022 | Volume: 99 | Issue: 6 | Pages: 1807-1816

10.1002/ccd.30093 | PMID 35066988 Get It

AbstractObjectivesTo compare all‐cause mortality in patients with mitral annulus calcification (MAC) and severe mitral valve dysfunction (MVD) who received standard mitral intervention versus no intervention.BackgroundPatients with MAC often have high surgical risk due to advanced age, comorbidities, and technical challenges related to calcium. The impact of a mitral intervention on outcomes of patients with MAC and severe MVD is not well known.MethodsRetrospective review of patients with MAC by transthoracic echocardiography (TTE) in 2015 at a single institution. Patients with severe mitral stenosis (MS) or regurgitation (MR) were analyzed and stratified into two groups: surgical or transcatheter intervention performed <1 year after the index TTE, and no or later intervention. The primary endpoint was all‐cause mortality.ResultsOf 5502 patients with MAC, 357 had severe MVD (MS = 27%, MR = 73%). Of those, 108 underwent mitral intervention (surgery = 87; transcatheter = 21). They were younger (73 ± 11 vs. 76 ± 11 years, p < 0.01) and less frequently had cardiovascular diseases compared with no‐intervention. Frequency in women was similar (45% vs. 50%, p = 0.44). During median follow‐up of 3.2 years, the intervention group had higher estimated survival than those without intervention (80% vs. 72% at 1 year and 55% vs. 35% at 4 year, p < 0.01). Adjusted for age, eGFR, LVEF < 50%, and pulmonary hypertension, mitral intervention was an independent predictor of lower mortality (hazard ratio = 0.66, 95% confidence interval 0.43–0.99, p = 0.046).ConclusionPatients with MAC and severe MVD who underwent mitral intervention <1 year from index TTE had lower mortality than those without intervention. Mitral intervention was independently associated with lower mortality.